• BIVDA members area

Members' Press Releases

From the monthly archives: March, 2018

We are pleased to present below all posts archived in 'March, 2018'. If you still can't find what you are looking for, try using the search box.

MBM and OCB launch ColoProg in China on March 7th 2018

Oxford developed prognostic assay for risk of post-surgical recurrence in
Stage II colorectal cancer patients to be available throughout China

Read the rest of entry »

Study confirms HORIBA POCT analyser enables earlier clinical decision-making in emergency paediatrics

Northampton, UK – 20th March 2018 – HORIBA UK Ltd, Medical announces that in a study recently undertaken and published as a case study by the Oxford Academic Health Science Network (AHSN), its Microsemi CRP point-of-care (POC) analyser was found to enable more rapid clinical decision-making, saving time and reducing costs, in emergency paediatric units. The study [1] found that using POCT as a replacement for laboratory tests resulted in earlier decision-making in approximately 75% of cases across three hospital sites. Economic analysis across these sites found that this could result in net annual cost savings due to reduced staff time, as well as faster decisions on antibiotic use.

Read the rest of entry »

OGT enhances customer experience with new Cytocell website

Oxford, UK – 7 March 2018. Oxford Gene Technology (OGT), The Molecular Genetics Company, has launched a new version of its Cytocell® fluorescence in situ hybridisation (FISH) probes website - designed to provide a wealth of information and advice, offer refined functionality, and be easy-to-use. Cytocell is well known for its complete and comprehensive range of FISH probes, exceptional customer support, service and expertise. In the spirit of sharing this expertise and knowledge, OGT has redeveloped the website to increase accessibility to the brand’s know-how.

Read the rest of entry »

Cytox awarded new Innovate UK funding for Alzheimer’s disease testing

8 March 2018: Oxford & Manchester, UK. Cytox, an emerging precision medicine leader providing genetic testing for Alzheimer’s disease, is pleased to announce that, in partnership with Cardiff University, the company has been awarded funding by Innovate UK. The award is £800,000 ($1.3m) out of a total project value of £1m ($1.6m) over two years.

Read the rest of entry »